Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $16.50 billion. The enterprise value is $16.81 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 222.57 million shares outstanding. The number of shares has decreased by -4.20% in one year.
| Current Share Class | 222.57M |
| Shares Outstanding | 222.57M |
| Shares Change (YoY) | -4.20% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.84% |
| Owned by Institutions (%) | 99.94% |
| Float | 220.52M |
Valuation Ratios
The trailing PE ratio is 29.78 and the forward PE ratio is 16.23. Hologic's PEG ratio is 1.74.
| PE Ratio | 29.78 |
| Forward PE | 16.23 |
| PS Ratio | 4.09 |
| Forward PS | 3.80 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 20.17 |
| P/FCF Ratio | 17.94 |
| P/OCF Ratio | 15.61 |
| PEG Ratio | 1.74 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.01, with an EV/FCF ratio of 18.27.
| EV / Earnings | 29.71 |
| EV / Sales | 4.10 |
| EV / EBITDA | 13.01 |
| EV / EBIT | 16.94 |
| EV / FCF | 18.27 |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.50.
| Current Ratio | 3.75 |
| Quick Ratio | 2.87 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 2.73 |
| Interest Coverage | 8.47 |
Financial Efficiency
Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 8.08%.
| Return on Equity (ROE) | 11.12% |
| Return on Assets (ROA) | 6.82% |
| Return on Invested Capital (ROIC) | 8.08% |
| Return on Capital Employed (ROCE) | 12.34% |
| Revenue Per Employee | $580,561 |
| Profits Per Employee | $80,093 |
| Employee Count | 7,063 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, Hologic has paid $115.50 million in taxes.
| Income Tax | 115.50M |
| Effective Tax Rate | 16.96% |
Stock Price Statistics
The stock price has decreased by -5.90% in the last 52 weeks. The beta is 0.71, so Hologic's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -5.90% |
| 50-Day Moving Average | 68.84 |
| 200-Day Moving Average | 64.64 |
| Relative Strength Index (RSI) | 70.46 |
| Average Volume (20 Days) | 4,821,133 |
Short Selling Information
The latest short interest is 3.50 million, so 1.57% of the outstanding shares have been sold short.
| Short Interest | 3.50M |
| Short Previous Month | 3.10M |
| Short % of Shares Out | 1.57% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
In the last 12 months, Hologic had revenue of $4.10 billion and earned $565.70 million in profits. Earnings per share was $2.49.
| Revenue | 4.10B |
| Gross Profit | 2.50B |
| Operating Income | 992.10M |
| Pretax Income | 681.20M |
| Net Income | 565.70M |
| EBITDA | 1.29B |
| EBIT | 992.10M |
| Earnings Per Share (EPS) | $2.49 |
Full Income StatementBalance Sheet
The company has $2.20 billion in cash and $2.51 billion in debt, giving a net cash position of -$305.20 million or -$1.37 per share.
| Cash & Cash Equivalents | 2.20B |
| Total Debt | 2.51B |
| Net Cash | -305.20M |
| Net Cash Per Share | -$1.37 |
| Equity (Book Value) | 5.05B |
| Book Value Per Share | 22.51 |
| Working Capital | 2.69B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.06 billion and capital expenditures -$137.00 million, giving a free cash flow of $920.10 million.
| Operating Cash Flow | 1.06B |
| Capital Expenditures | -137.00M |
| Free Cash Flow | 920.10M |
| FCF Per Share | $4.13 |
Full Cash Flow StatementMargins
Gross margin is 61.00%, with operating and profit margins of 24.19% and 13.80%.
| Gross Margin | 61.00% |
| Operating Margin | 24.19% |
| Pretax Margin | 16.61% |
| Profit Margin | 13.80% |
| EBITDA Margin | 31.51% |
| EBIT Margin | 24.19% |
| FCF Margin | 22.44% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.20% |
| Shareholder Yield | 4.20% |
| Earnings Yield | 3.43% |
| FCF Yield | 5.58% |
Dividend DetailsAnalyst Forecast
The average price target for Hologic is $79.00, which is 6.54% higher than the current price. The consensus rating is "Hold".
| Price Target | $79.00 |
| Price Target Difference | 6.54% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 5.50% |
| EPS Growth Forecast (5Y) | 22.46% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
